Replies to post #127486 on NorthWest Biotherapeutics Inc (NWBO)

[abeta]

doc -

thanks for connecting the dots - which I intellectually can't do ...

with respect to what you were trying to remember ....

2015

UCLA researchers create a promising new treatment for the deadliest form of brain cancer

A study led by Dr. Robert Prins and Dr. Linda Liau, both members of the UCLA Jonsson Comprehensive Cancer Center, looked at the impact of a combined treatment using a chemotherapy drug called

decitabine


and genetically modified immune cells. It is a continuation of previous research, published in 2011, that focused on the effect of decitabine on glioblastoma human cell cultures.

insert-text-here